Ekso Bionics Holdings Inc (EKSO)
1.33
+0.13
(+10.83%)
USD |
NASDAQ |
Apr 19, 16:00
1.36
+0.03
(+2.26%)
After-Hours: 20:00
Ekso Bionics Holdings Cash from Operations (Quarterly): -1.584M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.584M |
| September 30, 2023 | -3.353M |
| June 30, 2023 | -2.903M |
| March 31, 2023 | -4.214M |
| December 31, 2022 | -3.644M |
| September 30, 2022 | -2.59M |
| June 30, 2022 | -4.248M |
| March 31, 2022 | -4.206M |
| December 31, 2021 | -3.075M |
| September 30, 2021 | -2.475M |
| June 30, 2021 | -3.606M |
| March 31, 2021 | -2.00M |
| December 31, 2020 | -1.74M |
| September 30, 2020 | -1.27M |
| June 30, 2020 | -4.023M |
| March 31, 2020 | -1.722M |
| December 31, 2019 | -1.495M |
| September 30, 2019 | -4.569M |
| June 30, 2019 | -4.531M |
| March 31, 2019 | -5.177M |
| December 31, 2018 | -5.154M |
| September 30, 2018 | -4.207M |
| June 30, 2018 | -6.059M |
| March 31, 2018 | -6.745M |
| Date | Value |
|---|---|
| December 31, 2017 | -5.644M |
| September 30, 2017 | -8.723M |
| June 30, 2017 | -9.605M |
| March 31, 2017 | -7.254M |
| December 31, 2016 | -4.442M |
| September 30, 2016 | -6.433M |
| June 30, 2016 | -7.333M |
| March 31, 2016 | -6.789M |
| December 31, 2015 | -5.187M |
| September 30, 2015 | -4.62M |
| June 30, 2015 | -4.634M |
| March 31, 2015 | -3.828M |
| December 31, 2014 | -2.712M |
| September 30, 2014 | -3.586M |
| June 30, 2014 | -3.146M |
| March 31, 2014 | -5.563M |
| December 31, 2013 | -0.0019M |
| September 30, 2013 | -0.0015M |
| June 30, 2013 | -0.0272M |
| March 31, 2013 | -0.0003M |
| December 31, 2012 | -0.0018M |
| September 30, 2012 | -0.0013M |
| June 30, 2012 | -0.0086M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-4.569M
Minimum
Sep 2019
-1.27M
Maximum
Sep 2020
-3.013M
Average
-3.075M
Median
Dec 2021
Cash from Operations (Quarterly) Benchmarks
| Vicarious Surgical Inc | -11.37M |
| Perspective Therapeutics Inc | -9.008M |
| Xtant Medical Holdings Inc | -0.915M |
| Asensus Surgical Inc | -13.37M |
| Catheter Precision Inc | -1.889M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.043M |
| Free Cash Flow | -12.21M |
| Free Cash Flow Per Share (Quarterly) | -0.1126 |
| Free Cash Flow to Equity (Quarterly) | -1.393M |
| Free Cash Flow Yield | -66.22% |